Project Grant R43DA057708
Award Date 4/15/23
Completion Date 3/31/24
Dollars Obligated $519K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92121, USA
Similar Awards
- This $512,256 Project Grant from the National Institutes of Health's National Institute on Drug Abuse will support Health Outcomes Inc. doing business as Telesage to develop a Primary Care-SUD Intake System (P-SUD-IS). The P-SUD-IS aims to address underdiagnosis of substance use disorders (SUDs) by streamlining the SUD assessment process for primary care clinicians. Telesage will create a HIPAA-compliant, automated, cloud-based system to facilitate completion of biopsychosocial assessments for...
- SUD Care Transitions Research Project The National Institute on Drug Abuse (NIDA) awarded Kaiser Foundation Hospitals $3.24 million under the Drug Use and Addiction Research Programs (CFDA 93.279) on June 1, 2025, to comprehensively characterize and evaluate substance use disorder (SUD) care pathways. The project, scheduled for completion on February 28, 2030, will leverage Kaiser Permanente Washington's integrated healthcare system data—including electronic health records, insurance claims, and...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $823,809 to the University of Pittsburgh to develop and validate a suite of multidimensional measures of access to Medications for Opioid Use Disorder (MOUD) across U.S. states and the District of Columbia. The primary objectives are to: Create a Small Area Multidimensional MOUD Access (SAMMA) measure suite using public data sources. Validate and...
- This Project Grant award of $189,500 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to determine the extent of cardiovascular disease (CVD) among people with opioid use disorder (OUD) and explore ways to prevent CVD in this population. The key objectives are to: 1) examine the relationship between CVD and OUD using Transformed Medicaid Statistical Information System data, and 2) assess the impact of Medicaid Health Homes...
- This Project Grant award of $451,000.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to leverage natural language processing (NLP) and mixed methodologies to identify and classify medication treatment information needs of individuals with opioid use disorder (OUD) on the social media platform Reddit. The project has three key objectives: 1) Identify buprenorphine- and methadone-related treatment information needs...
- PEACE Platform Development and Evaluation Biomotivate LLC received $613,744 under a Project Grant from the National Institute on Drug Abuse (NIDA) Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 1, 2025, with completion targeted for July 31, 2026. The award funds development and evaluation of the PEACE Platform (Personalized Evocative Audiovisual Content for Everyone), a precision medicine tool designed to complement existing opioid use disorder (OUD) treatment...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is supporting the development of a software-based medical device (SAMD) for detecting opioid use through voice analysis. The $800,000 award to Tenvos Inc., a minority-owned and woman-owned technology company, aims to advance the company's AI-driven solution that can enable patients to remotely test for opioid use and securely share results with...
- The National Institute on Drug Abuse (NIDA) awarded a $188,307 Project Grant to the University of Pittsburgh under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2029. This award supports the development and testing of a guided, web-based behavioral treatment intervention that combines Acceptance and Commitment Therapy (ACT) for chronic pain with Mindfulness-Based Relapse Prevention (MBRP) for substance use disorders. The research...
- Federal Project Grant Award Summary The Medical University of South Carolina received a $2.69 million Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded June 1, 2025, with completion targeted for February 28, 2030. This research initiative will deliver a comprehensive, real-world assessment of social functioning changes among individuals with opioid use disorder (OUD) during treatment, integrating dual-perspective data...